Celecoxib: Not So Harmless?

Toxic epidermal necrolysis (TEN) is a severe and potentially fatal cutaneous reaction secondary to the use of drugs, including celecoxib. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that is widely prescribed to relieve arthralgia because of its better gastrointestinal tolerance. However, it may also be responsible for skin reactions, most of which are benign. Serious cutaneous adverse reactions have been reported in the form of acute generalized exanthematous pustulosis (AGEP). TEN secondary to celecoxib is poorly documented. Discontinuation of the suspected or causative drug(s), transfer of the patient to a specialist unit as quickly as possible, and supportive care are the cornerstones of patient management.

Authors

Publication Details

Journal
Cureus
Published
2026-07-23
DOI
https://doi.org/10.7759/cureus.113247
Primary Topic
Inflammatory mediators and NSAID effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Celecoxib: Not So Harmless?

Houssam Bkiyar, Ousmane Kaba, Bouchra Chahboun, Brahim Housni et al.
Cureus
Inflammatory mediators and NSAID effects
article

Celecoxib: Not So Harmless?

Houssam Bkiyar, Ousmane Kaba, Bouchra Chahboun, Brahim Housni, Maman Idi Chazali
article en

Abstract

Toxic epidermal necrolysis (TEN) is a severe and potentially fatal cutaneous reaction secondary to the use of drugs, including celecoxib. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that is widely prescribed to relieve arthralgia because of its better gastrointestinal tolerance. However, it may also be responsible for skin reactions, most of which are benign. Serious cutaneous adverse reactions have been reported in the form of acute generalized exanthematous pustulosis (AGEP). TEN secondary to celecoxib is poorly documented. Discontinuation of the suspected or causative drug(s), transfer of the patient to a specialist unit as quickly as possible, and supportive care are the cornerstones of patient management.

Cureus
Openalex Percentile: Top 10%
Inflammatory mediators and NSAID effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.